RIGIDFIX BIOCRYL 2.7MM BTB (210815), FEMORAL 3.3MM ST (210816), AND TIBIAL 3.3MM ST (210817) CROSS PIN KITS

K091041 · Depuy Mitek, A Johnson & Johnson Company · MAI · Aug 7, 2009 · Orthopedic

Device Facts

Record IDK091041
Device NameRIGIDFIX BIOCRYL 2.7MM BTB (210815), FEMORAL 3.3MM ST (210816), AND TIBIAL 3.3MM ST (210817) CROSS PIN KITS
ApplicantDepuy Mitek, A Johnson & Johnson Company
Product CodeMAI · Orthopedic
Decision DateAug 7, 2009
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

RigidFix Biocryl Cross Pin Kits The RigidFix Biocryl 2.7 mm BTB Cross Pin Kit is intended femoral and/or tibial fixation of autograft or allograft ACL Bone-tendon-bone grafts. The RigidFix Biocryl Fcmoral 3.3 mm ST Cross Pin Kit is intended for femoral fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). The RigidFix Biocryl Tibial 3.3 mm ST Cross Pin Kit is intended for tibial fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). BioIntrafix Tibial Tapered Sheaths and Screws The BioIntrafix Tibial Screw and Tibial Sheath are intended for fixation of soft tissue grafts during cruciate ligament reconstruction. Biocryl Interference Screws The Biocryl Interference Screw is indicated for the fixation of soft tissue grafts gr bone-tendon-bone grafts during cruciate ligament reconstruction surgeries of the knee.

Device Story

Absorbable orthopedic implants used for graft fixation in ACL reconstruction; includes cross pin kits, tibial tapered sheaths/screws, and interference screws. Implants manufactured from Biocryl (15% beta-TCP/85% PLA composite). Used by surgeons in clinical settings to secure grafts to femur or tibia. Implants are sterile, single-use; associated with reusable stainless steel instrumentation (guides, trocars, rods) for placement. Provides mechanical fixation of grafts to bone to facilitate healing. Submission supports 3-year shelf life based on 36-month stability study.

Clinical Evidence

No clinical data. Substantial equivalence supported by identical indications, materials, and design to predicates, with performance and safety data previously established in predicate 510(k) submissions.

Technological Characteristics

Absorbable implants composed of 15% beta-tricalcium phosphate (beta-TCP) and 85% polylactic acid (PLA) polymer. Includes cannulated, threaded fasteners and cross pins. Reusable instrumentation (guides, trocars) made of stainless steel. Sterile, single-patient use implants; non-sterile, reusable instruments. No software or electronic components.

Indications for Use

Indicated for fixation of autograft or allograft bone-tendon-bone or soft tissue (semitendinosus and gracillis) grafts during knee cruciate ligament reconstruction surgeries.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## SECTION 2 – 510(k) SUMMARY Raynham, MA 02767 DePuy Mitek, Inc. Regulatory Affairs Specialist a Johnson & Johnson company 325 Paramount Drive Raynham, MA 02767, USA Telephone: 508-977-3966 Zheng Liu RigidFix BiocryI Cross Pin Kits BioIntrafix Tibial Tapered Sheaths and Screws Biocryl Interference Screws AUG 0 7 2009 DePuy Mitek Submitter's Name and a Johnson & Johnson company Address: 325 Paramount Drive Contact Person Name of Medical Device Facsimile: 508-977-6955 e-mail: zliu8@its.jnj.com Classification Name: Single/multiple component metallic bone fixation appliances and accessories Common/Usual Name: Bone Anchor RigidFix Biocryl Cross Pin Kits Proprietary Name: BioIntrafix Tibial Tapered Sheaths and Screws Biocryl Interference Screws Substantial Equivalence and Restorative Deyice BioIntrafix Tibial Tapered Sheaths and Screws are substantially equivalent to: (Division Sign-Off) Division of Surgical, Orthopedic, 트 - K032167 BioIntrafix Tibial Tapered Sheaths and Screws (October 이 15, 2003). RigidFix Biocryl Cross Pin Kits are substantially equivalent to: K090669 RigidFix Biocryl Cross Pin Kits (April 03, 2009). Biocryl Interference Screws are substantially equivalent to: 510(k) Number - K013572 Biocryl Interference Screws (March 14, 2002). Premarket Notification: Traditional RigidFix Biocryl Cross Pin Kits, Biocryl Interference Screws, BioIntrafix Tibial Tapered Sheaths and Screws {1}------------------------------------------------ | Device Classification | These devices carry an FDA product code MAI, and subsequent code<br>HTY, and is classified as single/multiple component metallic bone<br>fixation appliances and accessories under 21 CFR 888.3030. | |------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Description | RigidFix Biocryl Cross Pin Kits | | | The proposed RigidFix Biocryl 2.7 mm BTB Cross Pins are<br>absorbable implants manufactured from "Biocryl" (15% ß-TCP/<br>85%PLA) material. The proposed RigidFix Biocryl 2.7 mm BTB Cross<br>Pins are used for the fixation of bone-tendon-bone grafts to the femur<br>and the tibia in Anterior Cruciate Ligament (ACL) reconstruction. A<br>total of four RigidFix Biocryl 2.7 mm BTB Cross Pins are used to<br>complete the reconstruction: two on the femur and two on the tibia. | | | The proposed RigidFix Biocryl Femoral 3.3 mm ST Cross Pins are<br>absorbable implants manufactured from "Biocryl" (15% ß-TCP/<br>85%PLA) material. The proposed RigidFix Biocryl Femoral 3.3 mm<br>ST Cross Pins are used for the fixation of soft tissue (semitendinosus<br>and gracillis) grafts to the femur in ACL reconstruction. Two RigidFix<br>Biocryl Femoral 3.3 mm ST Cross Pins are used to complete the repair. | | | The proposed RigidFix Biocryl Tibial 3.3 mm ST Cross Pins are<br>absorbable implants manufactured from "Biocryl" (15% ß-TCP/<br>85%PLA) material. The proposed RigidFix biocryl Tibial 3.3 mm ST<br>Cross Pins are used for the fixation of soft tissue (semitendinosus and<br>gracillis) grafts to the femur in ACL reconstruction. Two RigidFix<br>Biocryl Tibial 3.3 mm ST Cross Pins are used to complete the repair. | | (Division Sign-Off)<br>Division of Surgical, Orthopedic,<br>and Restorative Devices<br>510(k) Number | Each RigidFix Biocryl Cross Pin Kit is provided sterile and is for single<br>patient use only. | | | Except for the Interlocking Trocar and Sleeve assemblies that are<br>packaged in the RigidFix kits with the RigidFix Biocryl pins, other<br>reusable instrumentation is offered separately to assist in the placement<br>of the RigidFix Biocryl pins. The instrumentation consists of Tibial<br>Guide Frame, Tibial Rods, Long Stepped Trocar, Trocar Trial, Guide<br>Block Head Thumb Screw, Probe, Short Stepped Trocar, Tibial Pin<br>Insertion Rod and Femora/Tibial Rod Thumb Screw. These devices are<br>all stainless steel, non-sterile, reusable devices. In accordance to CFR<br>§888.4540, these are Class I devices and, therefore, are exempt from<br>510(k) premarketing notification procedures. Validated cleaning and<br>sterilization instructions are provided for those instruments. | | | BioIntrafix Tibial Tapered Sheaths and Screws | The DePuy Mitek BioIntrafix Tibial Tapered Screws and BioIntrafix Tibial Sheaths are absorbable implants made from a composite of absorbable Polylactic Acid (PLA) Polymer and Tricalcium Phosphate (TCP). They are used to secure soft tissue grafts to the bone during Premarket Notification: Traditional RigidFix Biocryl Cross Pin Kits, Biocryl Interference Screws, BioIntrafix Tibial Tapered Sheaths and Screws {2}------------------------------------------------ K091041 cruciate ligament reconstruction. The BioIntrafix Tibial Tapered Screws and BioIntrafix Tibial Sheaths are supplied sterile ready to use. The tie tensioner is a non-sterile, reusable instrument used to apply and measure tension on the graft. #### Biocryl Interference Screws The DePuy Mitek Biocryl Interference Screw is an absorbable, tapered, cannulated, threaded fastener for use in interference fixation of soft tissue grafts or bone-tendon grafts. The Interference Screw is made from a composite made of absorbable Poly Lactic Acid.(PLA) polymer and Tricalcium Phosphate (TCP). The Biocryl Interference Screw is packaged one per pouch. #### RigidFix Biocryl Cross Pin Kits The RigidFix Biocryl 2.7 mm BTB Cross Pin Kit is intended for femoral and/or tibial fixation of autograft or allograft ACL Bonetendon-bone grafts. The RigidFix Biocryl Femoral 3.3 mm ST Cross Pin Kit is intended for femoral fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). The RigidFix Biocryl Tibial 3.3 mm ST Cross Pin Kit is intended for tibial fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). ### BioIntrafix Tibial Tapered Sheaths and Screws The BioIntrafix Tibial Screw and Tibial Sheath are intended for fixation of soft tissue grafts during cruciate ligament reconstruction. #### Biocryl Interference Screws The Biocryl Interference Screw is indicated for the fixation of soft tissue grafts or bone-tendon-bone grafts during cruciate ligament reconstruction surgeries of the knee. This premarket notification is submitted to have the protocol of the 36month stability study reviewed to support a 3-year shelf life claim on the proposed products (i.e. RigidFix Biocryl Cross Pin Kits, BioIntrafix Tibial Tapered Sheaths and Screws, and Biocryl Interference Screws). No other changes have been made to the predicate devices. The proposed products have the same indication statements and the same technological characteristics (e.g., design, materials, etc.) as that of the respective predicate products. In addition, the descriptive characteristics are precise enough to establish substantial equivalence #### Premarket Notification: Traditional Safety and Performance RigidFix Biocryl Cross Pin Kits, Biocryl Interference Screws, BioIntrafix Tibial Tapered Sheaths and Screws ### Indications for Use {3}------------------------------------------------ K091041 between the proposed products and their respective predicates. Therefore, additional safety and performance testing on the proposed products are not necessary. Results of performance and safety testing have been submitted in the predicate 510(k)'s (i.e. K090669 for RigidFix Biocryl Cross Pin Kits, K032167 for BioIntrafix Tibial Sheaths and Screws, and K013572 for Biocryl Interference Screws) and have demonstrated that the devices are suitable for their intended use. Based on the identical indications for use and technological characteristics as compared to the predicate devices, the proposed RigidFix Biocryl Cross Pin Kits, BioIntrafix Tibial Sheaths and Screws, and Biocryl Interference Screws have shown to be substantially equivalent to their respective predicate devices under the Federal Food, Drug and Cosmetic Act. DK (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number 1109/04/ Premarket Notification: Traditional RigidFix Biocryl Cross Pin Kits, Biocryl Interference Screws, BioIntrafix Tibial Tapered Sheaths and Screws {4}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three wing-like strokes, positioned above a wavy, ribbon-like element. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol. Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002 DePuy Mitek A Johnson & Johnson Company % Ms. Zheng Liu Regulatory Affairs Specialist 325 Paramount Drive Raynham, Massachusetts 02767 # AUG 0 7 2009 Re: K091041 Trade/Device Name: RigidFix Biocryl Cross Pin Kits, BioIntrafix Tibial Tapered Sheaths and Screws, Biocryl Interference Screws Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: MAI, HTY, HWC Dated: July 15, 2009 Received: July 16, 2009 ### Dear Ms. Liu We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {5}------------------------------------------------ Page 2- Ms. Zheng Liu If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ K091041 # Indications for Use 510(k) Number (if known): Device Name: RigidFix Biocryl Cross Pin Kits BioIntrafix Tibial Tapered Sheaths and Screws Biocryl Interference Screws Indications for Use: #### RigidFix Biocryl Cross Pin Kits The RigidFix Biocryl 2.7 mm BTB Cross Pin Kit is intended femoral and/or tibial fixation of autograft or allograft ACL Bone-tendon-bone grafts. The RigidFix Biocryl Fcmoral 3.3 mm ST Cross Pin Kit is intended for femoral fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). The RigidFix Biocryl Tibial 3.3 mm ST Cross Pin Kit is intended for tibial fixation of autograft or allograft ACL soft tissue grafts (semitendinosus and gracillis). BioIntrafix Tibial Tapered Sheaths and Screws The BioIntrafix Tibial Screw and Tibial Sheath are intended for fixation of soft tissue grafts during cruciate ligament reconstruction. #### Biocryl Interference Screws The Biocryl Interference Screw is indicated for the fixation of soft tissue grafts gr bone-tendon-bone grafts during cruciate ligament reconstruction surgeries of the knee. | (Division Sign-Off) | |-----------------------------------| | Division of Surgical, Orthopedic, | | and Restorative Devices | | /09/04/ | Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR 51Qtkz Npggccccuntor Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of_1 Premarket Notification: Traditional RigidFix Biocryl Cross Pin Klts, Biocryl Interference Screws, BioIntrafix Tibial Tapered Sheaths and Screws
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...